Skip to main content
. 2020 Jul 12;12(7):1875. doi: 10.3390/cancers12071875

Figure 3.

Figure 3

Schematic overview of some of the players, targets, and strategies that are involved in modulating and re-educating the immunosuppressive TME for mCRC, with the aim of promoting anti-tumour immunity. An IDO1-expressing epithelial CRC cell (grey) is depicted in the middle.